Paydas, S. Et Al. 1996. Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?. DIALYSIS & TRANSPLANTATION , vol.25, no.6 , 344-346.

Paydas, S., SEYREK, N., & SAGLIKER, Y., (1996). Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?. DIALYSIS & TRANSPLANTATION , vol.25, no.6, 344-346.

Paydas, SAİME, NESLİHAN SEYREK, And Y SAGLIKER. "Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?," DIALYSIS & TRANSPLANTATION , vol.25, no.6, 344-346, 1996

Paydas, SAİME Et Al. "Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?." DIALYSIS & TRANSPLANTATION , vol.25, no.6, pp.344-346, 1996

Paydas, S. SEYREK, N. And SAGLIKER, Y. (1996) . "Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?." DIALYSIS & TRANSPLANTATION , vol.25, no.6, pp.344-346.

@article{article, author={SAİME PAYDAŞ Et Al. }, title={Does oral CaCO3 and calcitriol administration for secondary hyperparathyroidism treatment affect the lipid profile in HD patients?}, journal={DIALYSIS & TRANSPLANTATION}, year=1996, pages={344-346} }